Tag Archives: Orbifloxacin


Cause of Inflammatory Bowel Disease Inflammatory bowel disease (IBD) may be defined using clinical, histologic, immunologic, pathophysiologic, and genetic criteria. Clinical criteria Inflammatory bowel disease has been defined clinically as a spectrum of gastrointestinal disorders of an unknown cause that is associated with chronic inflammation of the stomach, intestine, or colon. A clinical diagnosis of… Read More »


Oxolinic acid, pipemidic acid, and nalidixic acid are 4-quinolone antibacterial agents. They are active against Gram-negative bacteria. However Gram-positive bacteria, Pseudomonas aeruginosa, and obligate anaerobes are not susceptible. Fluoroquinolone derivatives such as difloxacin, danofloxacin, enrofloxacin, flumequine, ibafloxacin, marbofloxacin, orbifloxacin, and sarafloxacin have a broader spectrum of activity than the parent compounds and are well distributed… Read More »